日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders

在慢性骨髓增生性疾病中,血小板增多症患者接受阿那格雷治疗后,TPO 水平升高,但可溶性 IL-6 受体水平不升高。

Palmblad, Jan; Björkholm, Magnus; Kutti, Jack; Lärfars, Gerd; Löfvenberg, Eva; Markevärn, Berit; Merup, Mats; Mauritzson, Nils; Westin, Jan; Samuelsson, Jan; Birgegård, Gunnar

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

来那度胺抑制恶性克隆并上调 5q 综合征患者中 SPARC 基因定位到常见缺失区域

Andrea Pellagatti, Martin Jädersten, Ann-Mari Forsblom, Helen Cattan, Birger Christensson, Emma K Emanuelsson, Mats Merup, Lars Nilsson, Jan Samuelsson, Birgitta Sander, James S Wainscoat, Jacqueline Boultwood, Eva Hellström-Lindberg